D. Carreon

1.7k total citations
16 papers, 951 citations indexed

About

D. Carreon is a scholar working on Psychiatry and Mental health, Clinical Psychology and Biological Psychiatry. According to data from OpenAlex, D. Carreon has authored 16 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 2 papers in Clinical Psychology and 2 papers in Biological Psychiatry. Recurrent topics in D. Carreon's work include Bipolar Disorder and Treatment (3 papers), Schizophrenia research and treatment (3 papers) and Tryptophan and brain disorders (2 papers). D. Carreon is often cited by papers focused on Bipolar Disorder and Treatment (3 papers), Schizophrenia research and treatment (3 papers) and Tryptophan and brain disorders (2 papers). D. Carreon collaborates with scholars based in United States, Canada and Germany. D. Carreon's co-authors include Kristen Day, Steven G. Potkin, Yi Jin, Gus Alva, B. Gerber, Glenn Richmond, Bala Gulasekaram, Júlia Costa, W.E. Bunney and Aaron S. Kemp and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biological Psychiatry.

In The Last Decade

D. Carreon

15 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Carreon United States	10	423	240	120	107	95	16	951
Ivonne Z. Jiménez‐Velázquez Puerto Rico	23	358 0.8×	220 0.9×	59 0.5×	62 0.6×	47 0.5×	58	1.5k
Chris Corcoran United States	25	634 1.5×	244 1.0×	50 0.4×	36 0.3×	64 0.7×	52	2.0k
Jesús Rivera‐Navarro Spain	17	285 0.7×	146 0.6×	27 0.2×	49 0.5×	50 0.5×	38	1.6k
Yuriko Katsumata United States	21	413 1.0×	102 0.4×	36 0.3×	28 0.3×	60 0.6×	78	1.3k
Jennifer L. Young United States	14	224 0.5×	125 0.5×	19 0.2×	34 0.3×	41 0.4×	50	1.2k
Stacy Salob United States	9	662 1.6×	142 0.6×	25 0.2×	12 0.1×	87 0.9×	12	1.1k
G. Costa Italy	17	54 0.1×	316 1.3×	55 0.5×	162 1.5×	31 0.3×	73	1.2k
Warren B. Zigman United States	32	664 1.6×	40 0.2×	69 0.6×	31 0.3×	151 1.6×	73	2.7k
Elena Navarro González Spain	19	461 1.1×	76 0.3×	37 0.3×	13 0.1×	176 1.9×	93	1.2k
Samantha M. Loi Australia	18	472 1.1×	258 1.1×	61 0.5×	10 0.1×	84 0.9×	103	1.2k

Countries citing papers authored by D. Carreon

Since Specialization

Citations

This map shows the geographic impact of D. Carreon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Carreon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Carreon more than expected).

Fields of papers citing papers by D. Carreon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Carreon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Carreon. The network helps show where D. Carreon may publish in the future.

Co-authorship network of co-authors of D. Carreon

This figure shows the co-authorship network connecting the top 25 collaborators of D. Carreon. A scholar is included among the top collaborators of D. Carreon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Carreon. D. Carreon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Garcia‐Manero, Guillermo, Melissa Ooi, Harinder Gill, et al.. (2023). Safety and Preliminary Efficacy of DFV890 in Adult Patients with Myeloid Diseases: A Phase 1b Study. Blood. 142(Supplement 1). 3250–3250. 4 indexed citations

Bardia, Aditya, Marina Parton, Sherko Kümmel, et al.. (2018). Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial. Journal of Clinical Oncology. 36(31). 3126–3133. 55 indexed citations

Fanale, Michelle A., Sarit Assouline, John Kuruvilla, et al.. (2013). Phase IA/II, multicentre, open‐label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non‐Hodgkin or Hodgkin lymphoma. British Journal of Haematology. 164(2). 258–265. 58 indexed citations

Jackevicius, Cynthia A., Jafna L. Cox, D. Carreon, et al.. (2009). Long-term trends in use of and expenditures for cardiovascular medications in Canada. Canadian Medical Association Journal. 181(1-2). E19–E28. 22 indexed citations

Glass, Andrew G., et al.. (2007). Incidencia de cáncer de mama, 1980-2006: roles combinados de la terapia hormonal menopáusica, la mamografía y el estado del receptor de estrógeno. 10(60). 258–271.

Jin, Yi, Steven G. Potkin, Aaron S. Kemp, et al.. (2005). Therapeutic Effects of Individualized Alpha Frequency Transcranial Magnetic Stimulation ( TMS) on the Negative Symptoms of Schizophrenia. Schizophrenia Bulletin. 32(3). 556–561. 99 indexed citations

Potkin, Steven G., Vincenzo S. Basile, Yi Jin, et al.. (2003). D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine. Molecular Psychiatry. 8(1). 109–113. 84 indexed citations

Potkin, Steven G., Gus Alva, John Panagides, et al.. (2003). Predicting Clinical Antipsychotic Doses from Preclinical and PET studies: A Case Study with Asenapine. 1 indexed citations

Potkin, Steven G., Per T. Thyrum, D. Carreon, et al.. (2002). Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability. Clinical Therapeutics. 24(11). 1809–1823. 18 indexed citations

10.

Day, Kristen, et al.. (2000). The Therapeutic Design of Environments for People With Dementia. The Gerontologist. 40(4). 397–416. 396 indexed citations

11.

Potkin, Steven G., et al.. (1996). Neuroimaging to evaluate atypical antipsychotic compounds: An FDG pet study of SDZ MAR 327. European Neuropsychopharmacology. 6. 17–18. 2 indexed citations

12.

Potkin, Steven G., et al.. (1994). S-adenosylmethionine blood levels in major depression: changes with drug treatment. Acta Neurologica Scandinavica. 89(S154). 15–18. 43 indexed citations

13.

Potkin, Steven G., Bala Gulasekaram, Júlia Costa, et al.. (1994). Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.. PubMed. 55 Suppl B. 133–6. 152 indexed citations

14.

Shapiro, Devora, et al.. (1993). Measuring the psychological construct of control. Discriminant, divergent, and incremental validity of the Shapiro Control Inventory and Rotter's and Wallstons' Locus of Control Scales.. PubMed. 40(1-4). 35–46. 12 indexed citations

15.

Potkin, Steven G., Bala Gulasekaram, Yi Jin, et al.. (1993). High and Low dose of clozapine compared in a double-blind study. Schizophrenia Research. 9(2-3). 246–247. 2 indexed citations

16.

Potkin, Steven G., et al.. (1989). Right visual field deficits in reaction time after invalid cues in chronic and never-medicated schizophrenics compared to normal controls. Biological Psychiatry. 25(7). A77–A77. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact